Publications by authors named "P I Bliganov"
Article Synopsis
- Renal cell cancer represents 2% of all cancers and is primarily managed through complete surgical resection when there is no spread to distant sites.
- Research on preoperative radiotherapy has shown no significant benefits, and the role of routine postoperative radiotherapy remains uncertain for localized cases post-surgery.
- Although malignant renal cell tumors are typically resistant to conventional radiation, newer high-dose radiation techniques, like stereotactic radiation therapy (SBRT), are emerging as effective treatment options with good control and low side effects, warranting further research for validation.
